Global pharmaceutical company Ferrer announces Wellthy Therapeutics as the winner of Ferrer 4 Future, a first-ever open innovation program launched by the company in November 2019.
The Ferrer 4 Future challenge was initiated by the Digital Health & Technology department at Ferrer, formed in 2019 with the goal to leverage digital health as a means to build a healthier and more sustainable society. The challenge aimed at finding entrepreneurs and digital health businesses that Ferrer could work collaboratively with to develop disruptive health solutions.
The Barcelona-based pharmaceutical company has long propagated its belief in putting the patient’s needs first. The Ferrer 4 Future challenge by extension is focussed on finding partners that can develop digital solutions across the patient care value chain (physicians, caregivers, payers, hospitals and so on) to address the patient’s needs in a manner that enhances their quality of life. The challenge included showcasing 65 start-ups across the globe.
"In Ferrer we are convinced that promoting innovation and digital health solutions is key to finding new ways of improving patients’ clinical outcomes and quality of life. That is why we created Ferrer 4 Future, our first-ever open innovation program launched by the company, as an active step towards collaborating with technology innovators to develop digital solutions across the patient care value chain. We are delighted to announce Wellthy Therapeutics as the winner, where we have found the right fit in both their digital therapeutic platform and their team. We are very much looking forward to collaborate as we strive together towards a common goal of better patient outcomes and quality of life”, said Gemma Estrada, Ferrer’s Head of Digital Health & Technology.
"Personalized, real time care for every patient is the future of healthcare, and real world outcomes is the new gold standard. Augmenting the existing standard of care with digital therapeutics allows better real world outcomes for all to get one step closer to reality. Long lasting, collaborative digital therapeutic partnerships with pharma allow for the creation ofmulti-modal therapeutics that deliver impact to all healthcare stakeholders. We are excited to win the Ferrer 4 Future challenge and look forward to a deeper collaboration with Ferrer as we march towards improving health outcomes and quality of life for patients globally,” said Abhishek Shah, CEO & Co-Founder, Wellthy Therapeutics.
Ferrer will work with Wellthy Therapeutics towards a commercial partnership, details of which are yet to be finalised.